Evidence map›Paper›PMID 31291578›Full record

ArticleCell reports2019

EphA2 Is a Neutrophil Receptor for Candida albicans that Stimulates Antifungal Activity during Oropharyngeal Infection.

Marc Swidergall, Norma V Solis, Zeping Wang, Quynh T Phan, Michaela E Marshall, Michail S Lionakis, Eric Pearlman, Scott G Filler

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Loss of Fgr41 inInfection and immunity · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Microorganisms · 2025
    Review
  15. Article
  16. Review
  17. The pathobiology of human fungal infections.Nature reviews. Microbiology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Marc SwidergallDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA; Institute for Infection and Immunity, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA. Electronic address: mswidergall@labiomed.org.
Norma V SolisDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA; Institute for Infection and Immunity, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Zeping WangDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Quynh T PhanDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA; Institute for Infection and Immunity, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Michaela E MarshallInstitute for Immunology, University of California, Irvine, Irvine, CA 92697, USA.
Michail S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA.
Eric PearlmanInstitute for Immunology, University of California, Irvine, Irvine, CA 92697, USA.
Scott G FillerDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA; Institute for Infection and Immunity, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA; David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA. Electronic address: sfiller@ucla.edu.
Harbor–UCLA Medical Center · USUCLA Medical Center · USUniversity of California, Irvine · USNational Institute of Allergy and Infectious Diseases · USThe Lundquist Institute · US

Funding

Immunopathogenesis of Fungal InfectionsZIAAI001175 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LIONAKIS, MICHAIL · 2012 to 2025
$23.9M
Pathogenesis of Fungal KeratitisR01EY018612 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2008 to 2022
$6.9M
C. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0M
Endothelial invasion by yeast-phase CandidaR01AI124566 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2016 to 2020
$2.7M
Novel Candida albicans host receptors during infection and immune responseK99DE026856 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SWIDERGALL, MARC · 2017 to 2018
$267k
Intramural NIH HHS ZIA AI001175NEI NIH HHS R01 EY018612NIAID NIH HHS R01 AI124566NIDCR NIH HHS K99 DE026856NIDCR NIH HHS R01 DE026600
6 · The paper itself

Abstract

During oropharyngeal candidiasis (OPC), Candida albicans proliferates and invades the superficial oral epithelium. Ephrin type-A receptor 2 (EphA2) functions as an oral epithelial cell β-glucan receptor that triggers the production of proinflammatory mediators in response to fungal infection. Because EphA2 is also expressed by neutrophils, we investigated its role in neutrophil candidacidal activity during OPC. We found that EphA2 on stromal cells is required for the accumulation of phagocytes in the oral mucosa of mice with OPC. EphA2 on neutrophils is also central to host defense against OPC. The interaction of neutrophil EphA2 with serum-opsonized C. albicans yeast activates the MEK-ERK signaling pathway, leading to NADPH subunit p47

Indexed as

Antifungal AgentsCandida albicansHumansMouth MucosaMycosesNeutrophilsReceptor, EphA2Antifungal AgentsReceptor, EphA2Candida albicansEphA2innate immunityneutrophiloropharyngeal candidiasispattern recognition receptor

Identifiers

PMID31291578
PMCPMC6638578
OpenAlexW2951827312

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.